Elsevier

Annals of Oncology

Volume 27, Issue 3, March 2016, Pages 546-547
Annals of Oncology

letters to the editor
Idiopathic thrombocytopenic purpura induced by nivolumab in a metastatic melanoma patient with elevated PD-1 expression on B cells

https://doi.org/10.1093/annonc/mdv580Get rights and content
Under an Elsevier user license
open archive

ABSTRACT

Nivolumab has shown promising early results in patients with advanced malignancies, including melanoma and lung cancer, with generally manageable side effects. On the other hand, recent studies showed that the immune activation caused by PD-1 blockade might promote severe autoimmune toxicity. Herein, we report a case of idiopathic thrombocytopenic purpura during nivolumab therapy.

Cited by (0)